Caprock Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$650K Buy
8,965
+554
+7% +$40.2K 0.02% 618
2024
Q4
$623K Buy
+8,411
New +$623K 0.02% 551
2024
Q2
Sell
-6,640
Closed -$635K 879
2024
Q1
$635K Buy
6,640
+39
+0.6% +$3.73K 0.04% 351
2023
Q4
$503K Sell
6,601
-2,010
-23% -$153K 0.03% 387
2023
Q3
$597K Buy
8,611
+392
+5% +$27.2K 0.05% 325
2023
Q2
$775K Sell
8,219
-572
-7% -$54K 0.06% 266
2023
Q1
$727K Buy
+8,791
New +$727K 0.06% 264
2022
Q4
Sell
-9,621
Closed -$795K 576
2022
Q3
$795K Buy
+9,621
New +$795K 0.08% 186
2022
Q2
Sell
-10,607
Closed -$1.25M 578
2022
Q1
$1.25M Buy
+10,607
New +$1.25M 0.12% 136
2021
Q2
Sell
-9,375
Closed -$784K 529
2021
Q1
$784K Sell
9,375
-151
-2% -$12.6K 0.09% 174
2020
Q4
$866K Buy
9,526
+1,085
+13% +$98.6K 0.1% 152
2020
Q3
$674K Sell
8,441
-295
-3% -$23.6K 0.09% 165
2020
Q2
$604K Buy
8,736
+2,379
+37% +$164K 0.09% 169
2020
Q1
$400K Buy
6,357
+126
+2% +$7.93K 0.08% 186
2019
Q4
$485K Sell
6,231
-60
-1% -$4.67K 0.09% 168
2019
Q3
$461K Sell
6,291
-99
-2% -$7.26K 0.09% 166
2019
Q2
$393K Sell
6,390
-870
-12% -$53.5K 0.08% 194
2019
Q1
$463K Buy
7,260
+2,367
+48% +$151K 0.09% 189
2018
Q4
$250K Sell
4,893
-3,126
-39% -$160K 0.06% 275
2018
Q3
$465K Sell
8,019
-2,337
-23% -$136K 0.09% 176
2018
Q2
$503K Buy
10,356
+576
+6% +$28K 0.11% 168
2018
Q1
$455K Hold
9,780
0.1% 200
2017
Q4
$394K Buy
9,780
+825
+9% +$33.2K 0.08% 234
2017
Q3
$326K Buy
8,955
+885
+11% +$32.2K 0.07% 265
2017
Q2
$318K Buy
+8,070
New +$318K 0.07% 266
2017
Q1
Sell
-9,249
Closed -$289K 360
2016
Q4
$289K Sell
9,249
-519
-5% -$16.2K 0.07% 237
2016
Q3
$393K Buy
+9,768
New +$393K 0.09% 215